Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Linearis has launched a state-of-the-art laboratory integrating high-throughput metabolomics with artificial intelligence. The company provides comprehensive health status analyses based on over 1,300–1,400 metabolic biomarkers using mass spectrometry. Their platform supports prevention, screening, treatment monitoring, and accelerates new drug discovery for metabolic diseases such as cancer and diabetes. They also operate a ventures fund investing directly in innovative AI-powered life science companies. No published clinical results for proprietary therapeutics; their impact is through enabling research/discovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Linearis.